ABC | Volume 111, Nº4, Outubro 2018

Artigo Original Borges et al O manejo inadequado de antiagregantes plaquetários Arq Bras Cardiol. 2018; 111(4):596-604 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 30. Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al; CURRENT-OASIS 7 trial investigators. Double-dose versus standard- dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet. 2010;376(9748):1233-43. 31. Li L, Geraghty OC, Mehta Z, Rothwell PM, Study OV. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet. 2017;390(10093):490-9. 32. Olivetti G. Melissari M, Capasso JM, Anversa P. Cardiomyopaty of the aging human heart: myocyte loss and reactive cellular hypertrophy. Cir Res.1991;68(6):1560-8. 33. Fernandes EO, Guerra EE, Pitrez FA, Fernandes FM, Rosito GB, Gonzáles HE, et al. Avaliação pré-operatória e cuidados em cirurgia eletiva: recomendações baseadas em evidências. Revista da AMRIGS, Porto Alegre. 2010;54(2):240-58. 34. Stracieri LD. Cuidados e complicações pós-operatórias. Medicina (Ribeirão Preto). 2008;41(4):465-8. 35. Qureshi AI, Suri MF, Saad M, Hopkins LN. Educational attainment and risk of stroke andmyocardial infarction. Med Sci Monit. 2003;9(11):CR466-73. 36. Samal D, Greisenegger S, Auff E, Lang W, Lalouschek W. The relation between knowledge about hypertension and education in hospitalized patients with stroke in Vienna. Stroke. 2007;38(4):1304-8. 37. Skowron KB, Angelos P. Surgical informed consent revisited: time to revise the routine? World J Surg. 2017;41(1):1-4. 38. GersteinNS, Schulman PM, GersteinWH, Petersen TR, Tawil I. Shouldmore patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012;255(5):811-9. 604

RkJQdWJsaXNoZXIy MjM4Mjg=